Volume 10, Issue 5 (September & October 2019)                   BCN 2019, 10(5): 527-540 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kamali Dolatabadi L, Emamghoreishi M, Namavar M R, Badeli Sarkala H. Curcumin Effects on Memory Impairment and Restoration of Irregular Neuronal Distribution in the Hippocampal CA1 Region After Global Cerebral Ischemia in Male Rats. BCN 2019; 10 (5) :527-540
URL: http://bcn.iums.ac.ir/article-1-1144-en.html
1- Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
2- 2-1.Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; 2-2. Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; 2-3.Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran.
3- 3-1.Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; 3-2. Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; 3-3.Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract:  
Introduction: Global Cerebral Ischemia (GCI) causes neuronal damage with subsequent neurological and cognitive impairments. Curcumin has anti-inflammatory, antioxidant, and neuroprotective properties, which makes it a potential candidate for improving GCI-induced impairments. This study aimed to investigate the effects of curcumin on the neurological and memory deficits, as well as spatial neuronal distribution in the CA1 region after GCI in rats.
Methods: 56 Sprague-Dawley male rats were randomly assigned into 4 groups of sham (n=14), control (n=14), curcumin 50 mg/kg (n=14), and curcumin 100 mg/kg (n=14). Each group was divided into the two subgroups of short-term (7 days) and long-term (28 days) treatment periods. The neurological severity score (NSS), passive avoidance task, and the traction test were performed at postoperative days of 0, 1, 2, 3, 7, 14, 21, and 28. The novel object recognition test and Voronoi tessellation were carried out on days 7 and 28 after GCI.
Results: Curcumin 100 mg/kg significantly decreased neurological severity score on postoperative days of 7 and 28 compared with the control (P<0.001) and curcumin 50 mg/kg groups (P<0.05-P<0.001). Also, curcumin 100 mg/kg significantly increased step-through latency times on postoperative days of 3-28 and 14-28 compared with the control (P<0.05-P<0.001) and curcumin 50 mg/kg groups (P<0.01-P<0.001). Moreover, it increased the novelty preference index during the novel object recognition test in the 28-day treatment subgroup after GCI. Curcumin (100 mg/kg) could maintain the neuronal aggregation in the CA1 region after GCI at a level near to what is generally observed in normal rats.
Conclusion: Curcumin could improve memory and neurological deficits and restore irregular neuronal distribution in the CA1 region after GCI in a time-dependent manner, and its higher dose was more effective than its lower dose. Curcumin may have beneficial effects on reducing brain complications after ischemia.
Full-Text [PDF 1143 kb]   |   |   Full-Text (HTML)   
Type of Study: Original | Subject: Behavioral Neuroscience
Received: 2018/03/12 | Accepted: 2018/10/3 | Published: 2019/09/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb